Table 6

Use of Oral Corticosteroid Pulses for Asthma Symptoms

Oral Corticosteroid Pulses: Events/Subject/Year

(Percent of Subjects)

Total Number of Subjects

BT

Control

Year 1 ^a

BT = 45

Control = 24

0.60 (24.5%) ^c

0.42 (20.8%) ^c

Year 2

BT = 45

Control = 24

0.49 (24.5%)

0.54 (33.3%)

Year 3

BT = 43

Control = 21

0.33 (25.6%)

0.52 (23.8%)

Year 4 ^b

BT = 43

Control = 0

0.63 (27.9%)

--

Year 5 ^b

BT = 42

Control = 0

0.62 (30.9%)

--

a: Year 1 data only for subjects who enrolled for longer-term follow-up.

b: Control group subjects exited from Study after Year 3 evaluations.

c: Includes adverse events reported as "Asthma", "Exacerbations of asthma", "Wheeze", "Dyspnea", and "Respiratory infection".

Thomson et al. BMC Pulmonary Medicine 2011 11:8   doi:10.1186/1471-2466-11-8